eCAM Advance Access published online on October 6, 2004
eCAM, doi:10.1093/ecam/neh042
Copyright © 2004 by the Oxford University Press.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Food Science and Technology, College of Bioresource Sciences, Nihon University, Japan
* To whom correspondence should be addressed. E-mail: masanobu-nanno{at}yakult.co.jp.
Evidence is rapidly accumulating as to the beneficial effects of foods. However, it is not always clear whether the information is based on data evaluated impartially in a scientific fashion. Human research into whether foods modulate immune functions in either intervention studies or randomized controlled trials can be classified into three categories according to the physical state of subjects enrolled for investigation: (i) studies examining the effect of foods in healthy individuals; (ii) studies analyzing the effect of foods on patients with hypersensitivity; and (iii) studies checking the effect of foods on immunocompromized subjects, including patients who had undergone surgical resection of cancer and newborns. The systematization of reported studies has made it reasonable to conclude that foods are able to modulate immune functions manifesting as either innate immunity (phagocytic activity, NK cell activity) or acquired immunity (T cell response, antibody production). Moreover, improvement of immune functions by foods can normalize the physical state of allergic patients or cancer patients, and may reduce the risk of diseases in healthy individuals. Therefore, it is valuable to assess the immune-modulating abilities of foods by measuring at least one parameter of either innate or acquired immunity.
Accepted August 31, 2004
Review
Modulation of Immune Functions by Foods
2 Yakult Central Institute for Microbiological Research, Japan
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. Shin, M. Suzuki, T. Mizutani, and N. Susa Improvement of Experimentally Induced Hepatic and Renal Disorders in Rats using Lactic Acid Bacteria-fermented Soybean Extract (BiofermenticsTM) Evid. Based Complement. Altern. Med., September 1, 2009; 6(3): 357 - 363. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu, Y. Fukuwatari, K. Okumura, K. Takeda, K.-i. Ishibashi, M. Furukawa, N. Ohno, K. Mori, M. Gao, and M. Motoi Immunomodulating Activity of Agaricus brasiliensis KA21 in Mice and in Human Volunteers Evid. Based Complement. Altern. Med., June 1, 2008; 5(2): 205 - 219. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Secor Jr, W. F. Carson IV, A. Singh, M. Pensa, L. A. Guernsey, C. M. Schramm, and R. S. Thrall Oral Bromelain Attenuates Inflammation in an Ovalbumin-induced Murine Model of Asthma Evid. Based Complement. Altern. Med., March 1, 2008; 5(1): 61 - 69. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hirose, S. Murosaki, Y. Yamamoto, Y. Yoshikai, and T. Tsuru Daily Intake of Heat-Killed Lactobacillus plantarum L-137 Augments Acquired Immunity in Healthy Adults J. Nutr., December 1, 2006; 136(12): 3069 - 3073. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vojdani and J. Erde Regulatory T Cells, a Potent Immunoregulatory Target for CAM Researchers: Modulating Tumor Immunity, Autoimmunity and Alloreactive Immunity (III) Evid. Based Complement. Altern. Med., September 1, 2006; 3(3): 309 - 316. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Cooper Role of TOLL-like Receptors in Adjuvant-Augmented Immune Therapies by T. Seya. Evid. Based Complement. Altern. Med., March 1, 2006; 3(1): 133 - 137. [Full Text] [PDF] |
||||
![]() |
A. Vojdani and J. Erde Regulatory T Cells, a Potent Immunoregulatory Target for CAM Researchers: The Ultimate Antagonist (I). Evid. Based Complement. Altern. Med., March 1, 2006; 3(1): 25 - 30. [Abstract] [Full Text] [PDF] |
||||

